Old Web
English
Sign In
Acemap
>
authorDetail
>
Ole C. Thomsen
Ole C. Thomsen
Disease
Medicine
General surgery
Diabetes mellitus
Internal medicine
4
Papers
108
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial
2014
The American Journal of Gastroenterology
Casper Steenholdt
Klaus Bendtzen
Jørn Brynskov
Ole C. Thomsen
Mark A Ainsworth
Show All
Source
Cite
Save
Citations (106)
Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohnʼs Disease Patients with Infliximab Treatment Failure: 1546
2012
The American Journal of Gastroenterology
Casper Steenholdt
Jørn Brynskov
Ole C. Thomsen
Lars Munck
Jan Fallingborg
Lisbet Ambrosius Christensen
Gitte Pedersen
Jens Kjeldsen
Klaus Bendtzen
Steven Lockton
Scott Hauenstein
Reshma Shringarpure
Emil Chuang
Sharat Singh
Mark A. Ainsworth
Show All
Source
Cite
Save
Citations (0)
Long-term Remission with Certolizumab Pegol in Crohnʼs Disease over 3.5 Years: Results from the PRECiSE 3 Study: 1213
2009
The American Journal of Gastroenterology
Gary R. Lichtenstein
Ole C. Thomsen
Stefan Schreiber
Ian C. Lawrance
Stephen B. Hanauer
Ralph Bloomfield
William J. Sandborn
Show All
Source
Cite
Save
Citations (0)
Rapid Improvement of Patient-reported CDAI Diary Components by Day 8 in Active Crohnʼs Disease Patients Treated with Certolizumab Pegol: 1194
2009
The American Journal of Gastroenterology
Stefan Schreiber
Mani Khaliq-Kareemi
Ian C. Lawrance
Ole C. Thomsen
Ralph Bloomfield
William J. Sandborn
Show All
Source
Cite
Save
Citations (2)
1